Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 50

1.

Correction to: Evidence that DNA repair genes, a family of tumor suppressor genes, are associated with evolution rate and size of genomes.

Voskarides K, Dweep H, Chrysostomou C.

Hum Genomics. 2019 Jul 2;13(1):29. doi: 10.1186/s40246-019-0214-6.

2.

Evidence that DNA repair genes, a family of tumor suppressor genes, are associated with evolution rate and size of genomes.

Voskarides K, Dweep H, Chrysostomou C.

Hum Genomics. 2019 Jun 7;13(1):26. doi: 10.1186/s40246-019-0210-x. Erratum in: Hum Genomics. 2019 Jul 2;13(1):29.

3.

The "cancer-cold" hypothesis and possible extensions for the Nordic populations.

Voskarides K.

Scand J Public Health. 2019 Jul;47(5):477-481. doi: 10.1177/1403494819831905. Epub 2019 Feb 28.

PMID:
30813844
4.

Genes that improved fitness also cost modern humans: evidence for genes with antagonistic effects on longevity and disease.

Byars SG, Voskarides K.

Evol Med Public Health. 2019 Jan 23;2019(1):4-6. doi: 10.1093/emph/eoz002. eCollection 2019. No abstract available.

5.

Influenza Virus-Host Co-evolution. A Predator-Prey Relationship?

Voskarides K, Christaki E, Nikolopoulos GK.

Front Immunol. 2018 Sep 7;9:2017. doi: 10.3389/fimmu.2018.02017. eCollection 2018. Review.

6.

COL4A5 and LAMA5 variants co-inherited in familial hematuria: digenic inheritance or genetic modifier effect?

Voskarides K, Papagregoriou G, Hadjipanagi D, Petrou I, Savva I, Elia A, Athanasiou Y, Pastelli A, Kkolou M, Hadjigavriel M, Stavrou C, Pierides A, Deltas C.

BMC Nephrol. 2018 May 16;19(1):114. doi: 10.1186/s12882-018-0906-5.

7.

Group Selection May Explain Cancer Predisposition and Other Human Traits' Evolution.

Voskarides K.

J Mol Evol. 2018 Apr;86(3-4):184-186. doi: 10.1007/s00239-018-9841-0. Epub 2018 Apr 5.

PMID:
29623350
8.
9.

Distal renal tubular acidosis in a Libyan patient: Evidence for digenic inheritance.

Nagara M, Papagregoriou G, Ben Abdallah R, Landoulsi Z, Bouyacoub Y, Elouej S, Kefi R, Pippucci T, Voskarides K, Bashamboo A, McElreavey K, Hachicha M, Romeo G, Seri M, Deltas C, Abdelhak S.

Eur J Med Genet. 2018 Jan;61(1):1-7. doi: 10.1016/j.ejmg.2017.10.002. Epub 2017 Oct 9.

PMID:
29024829
10.

Frequent COL4 mutations in familial microhematuria accompanied by later-onset Alport nephropathy due to focal segmental glomerulosclerosis.

Papazachariou L, Papagregoriou G, Hadjipanagi D, Demosthenous P, Voskarides K, Koutsofti C, Stylianou K, Ioannou P, Xydakis D, Tzanakis I, Papadaki A, Kallivretakis N, Nikolakakis N, Perysinaki G, Gale DP, Diamantopoulos A, Goudas P, Goumenos D, Soloukides A, Boletis I, Melexopoulou C, Georgaki E, Frysira E, Komianou F, Grekas D, Paliouras C, Alivanis P, Vergoulas G, Pierides A, Daphnis E, Deltas C.

Clin Genet. 2017 Nov;92(5):517-527. doi: 10.1111/cge.13077. Epub 2017 Sep 25.

PMID:
28632965
11.

A functional variant in NEPH3 gene confers high risk of renal failure in primary hematuric glomerulopathies. Evidence for predisposition to microalbuminuria in the general population.

Voskarides K, Stefanou C, Pieri M, Demosthenous P, Felekkis K, Arsali M, Athanasiou Y, Xydakis D, Stylianou K, Daphnis E, Goulielmos G, Loizou P, Savige J, Höhne M, Völker LA, Benzing T, Maxwell PH, Gale DP, Gorski M, Böger C, Kollerits B, Kronenberg F, Paulweber B, Zavros M, Pierides A, Deltas C.

PLoS One. 2017 Mar 23;12(3):e0174274. doi: 10.1371/journal.pone.0174274. eCollection 2017.

12.

Y chromosome and cardiovascular risk: What are we missing?

Voskarides K.

Atherosclerosis. 2017 Apr;259:97-98. doi: 10.1016/j.atherosclerosis.2017.02.026. Epub 2017 Mar 1. No abstract available.

PMID:
28279402
13.

Correction: A European Spectrum of Pharmacogenomic Biomarkers: Implications for Clinical Pharmacogenomics.

Mizzi C, Dalabira E, Kumuthini J, Dzimiri N, Balogh I, Başak N, Böhm R, Borg J, Borgiani P, Bozina N, Bruckmueller H, Burzynska B, Carracedo A, Cascorbi I, Deltas C, Dolzan V, Fenech A, Grech G, Kasiulevicius V, Kádaši Ľ, Kučinskas V, Khusnutdinova E, Loukas YL, Macek M Jr, Makukh H, Mathijssen R, Mitropoulos K, Mitropoulou C, Novelli G, Papantoni I, Pavlovic S, Saglio G, Sertić J, Stojiljkovic M, Stubbs AP, Squassina A, Torres M, Turnovec M, van Schaik RH, Voskarides K, Wakil SM, Werk A, Del Zompo M, Zukic B, Katsila T, Lee MT, Motsinger-Rief A, Mc Leod HL, van der Spek PJ, Patrinos GP.

PLoS One. 2017 Feb 16;12(2):e0172595. doi: 10.1371/journal.pone.0172595. eCollection 2017.

14.

Plasticity vs Mutation. The role of microRNAs in human adaptation.

Voskarides K.

Mech Ageing Dev. 2017 Apr;163:36-39. doi: 10.1016/j.mad.2016.12.014. Epub 2017 Jan 3. Review.

PMID:
28057445
15.

'Plasticity-First' Evolution and the Role of miRNAs: A Comment on Levis and Pfennig.

Voskarides K.

Trends Ecol Evol. 2016 Nov;31(11):816-817. doi: 10.1016/j.tree.2016.08.006. Epub 2016 Sep 14. No abstract available.

PMID:
27637167
16.

A European Spectrum of Pharmacogenomic Biomarkers: Implications for Clinical Pharmacogenomics.

Mizzi C, Dalabira E, Kumuthini J, Dzimiri N, Balogh I, Başak N, Böhm R, Borg J, Borgiani P, Bozina N, Bruckmueller H, Burzynska B, Carracedo A, Cascorbi I, Deltas C, Dolzan V, Fenech A, Grech G, Kasiulevicius V, Kádaši Ľ, Kučinskas V, Khusnutdinova E, Loukas YL, Macek M Jr, Makukh H, Mathijssen R, Mitropoulos K, Mitropoulou C, Novelli G, Papantoni I, Pavlovic S, Saglio G, Setric J, Stojiljkovic M, Stubbs AP, Squassina A, Torres M, Turnovec M, van Schaik RH, Voskarides K, Wakil SM, Werk A, Del Zompo M, Zukic B, Katsila T, Lee MT, Motsinger-Rief A, Mc Leod HL, van der Spek PJ, Patrinos GP.

PLoS One. 2016 Sep 16;11(9):e0162866. doi: 10.1371/journal.pone.0162866. eCollection 2016. Erratum in: PLoS One. 2017 Feb 16;12 (2):e0172595.

17.

Y-chromosome phylogeographic analysis of the Greek-Cypriot population reveals elements consistent with Neolithic and Bronze Age settlements.

Voskarides K, Mazières S, Hadjipanagi D, Di Cristofaro J, Ignatiou A, Stefanou C, King RJ, Underhill PA, Chiaroni J, Deltas C.

Investig Genet. 2016 Feb 11;7:1. doi: 10.1186/s13323-016-0032-8. eCollection 2016.

18.

Molecular and Clinical Investigation of Cystinuria in the Greek-Cypriot Population.

Athanasiou Y, Voskarides K, Chatzikyriakidou A, Ignatiou A, Demosthenous P, Elia A, Zavros M, Georgiou I, Pierides A, Deltas C.

Genet Test Mol Biomarkers. 2015 Nov;19(11):641-5. doi: 10.1089/gtmb.2015.0144. Epub 2015 Nov 5.

PMID:
26540609
19.

Carriers of Autosomal Recessive Alport Syndrome with Thin Basement Membrane Nephropathy Presenting as Focal Segmental Glomerulosclerosis in Later Life.

Deltas C, Savva I, Voskarides K, Papazachariou L, Pierides A.

Nephron. 2015;130(4):271-80. doi: 10.1159/000435789. Epub 2015 Jul 17. Review.

PMID:
26201269
20.

Homo sapiens exhibit a distinct pattern of CNV genes regulation: an important role of miRNAs and SNPs in expression plasticity.

Dweep H, Kubikova N, Gretz N, Voskarides K, Felekkis K.

Sci Rep. 2015 Jul 16;5:12163. doi: 10.1038/srep12163.

21.

Co-Inheritance of Functional Podocin Variants with Heterozygous Collagen IV Mutations Predisposes to Renal Failure.

Stefanou C, Pieri M, Savva I, Georgiou G, Pierides A, Voskarides K, Deltas C.

Nephron. 2015;130(3):200-12. doi: 10.1159/000432406. Epub 2015 Jun 26.

PMID:
26138234
22.

A novel splice-site mutation in ATP6V0A4 gene in two brothers with distal renal tubular acidosis from a consanguineous Tunisian family.

Nagara M, Voskarides K, Elouej S, Zaravinos A, Riahi Z, Papagregoriou G, Kefi R, Boussetta K, Deltas C, Abdelhak S, Tinsa F.

J Genet. 2014 Dec;93(3):859-63. No abstract available.

23.

Frequency of COL4A3/COL4A4 mutations amongst families segregating glomerular microscopic hematuria and evidence for activation of the unfolded protein response. Focal and segmental glomerulosclerosis is a frequent development during ageing.

Papazachariou L, Demosthenous P, Pieri M, Papagregoriou G, Savva I, Stavrou C, Zavros M, Athanasiou Y, Ioannou K, Patsias C, Panagides A, Potamitis C, Demetriou K, Prikis M, Hadjigavriel M, Kkolou M, Loukaidou P, Pastelli A, Michael A, Lazarou A, Arsali M, Damianou L, Goutziamani I, Soloukides A, Yioukas L, Elia A, Zouvani I, Polycarpou P, Pierides A, Voskarides K, Deltas C.

PLoS One. 2014 Dec 16;9(12):e115015. doi: 10.1371/journal.pone.0115015. eCollection 2014.

24.

Molecular investigation of distal renal tubular acidosis in Tunisia, evidence for founder mutations.

Nagara M, Voskarides K, Nouira S, Ben Halim N, Kefi R, Aloulou H, Romdhane L, Ben Abdallah R, Ben Rhouma F, Aissa K, Boughamoura L, Kammoun T, Azzouz H, Abroug S, Ben Turkia H, Ayadi A, Mrad R, Chabchoub I, Hachicha M, Chemli J, Deltas C, Abdelhak S.

Genet Test Mol Biomarkers. 2014 Nov;18(11):741-8. doi: 10.1089/gtmb.2014.0175. Epub 2014 Oct 6.

25.

Genetic epidemiology of cancer predisposition DNA repair genes is probably related with ancestral surviving under adverse environmental conditions.

Voskarides K.

Genet Test Mol Biomarkers. 2014 Aug;18(8):533-7. doi: 10.1089/gtmb.2014.0053. Epub 2014 Jun 16.

PMID:
24933130
26.

Evidence for contribution of the y chromosome in atherosclerotic plaque occurrence in men.

Voskarides K, Hadjipanagi D, Papazachariou L, Griffin M, Panayiotou AG.

Genet Test Mol Biomarkers. 2014 Aug;18(8):552-6. doi: 10.1089/gtmb.2014.0020. Epub 2014 Apr 10.

PMID:
24720269
27.

Genetic polymorphisms in warfarin and tacrolimus-related genes VKORC1, CYP2C9 and CYP3A5 in the Greek-Cypriot population.

Hadjipanagi D, Chrysanthou S, Voskarides K, Deltas C.

BMC Res Notes. 2014 Mar 5;7:123. doi: 10.1186/1756-0500-7-123.

28.
29.

CNVs-microRNAs interactions demonstrate unique characteristics in the human genome. An interspecies in silico analysis.

Dweep H, Georgiou GD, Gretz N, Deltas C, Voskarides K, Felekkis K.

PLoS One. 2013 Dec 2;8(12):e81204. doi: 10.1371/journal.pone.0081204. eCollection 2013.

30.

Evidence for activation of the unfolded protein response in collagen IV nephropathies.

Pieri M, Stefanou C, Zaravinos A, Erguler K, Stylianou K, Lapathitis G, Karaiskos C, Savva I, Paraskeva R, Dweep H, Sticht C, Anastasiadou N, Zouvani I, Goumenos D, Felekkis K, Saleem M, Voskarides K, Gretz N, Deltas C.

J Am Soc Nephrol. 2014 Feb;25(2):260-75. doi: 10.1681/ASN.2012121217. Epub 2013 Nov 21.

31.

Molecular genetics of familial hematuric diseases.

Deltas C, Pierides A, Voskarides K.

Nephrol Dial Transplant. 2013 Dec;28(12):2946-60. doi: 10.1093/ndt/gft253. Epub 2013 Sep 17. Review.

PMID:
24046192
32.

Epistatic role of the MYH9/APOL1 region on familial hematuria genes.

Voskarides K, Demosthenous P, Papazachariou L, Arsali M, Athanasiou Y, Zavros M, Stylianou K, Xydakis D, Daphnis E, Gale DP, Maxwell PH, Elia A, Pattaro C, Pierides A, Deltas C.

PLoS One. 2013;8(3):e57925. doi: 10.1371/journal.pone.0057925. Epub 2013 Mar 14.

33.

C3 glomerulonephritis/CFHR5 nephropathy is an endemic disease in Cyprus: clinical and molecular findings in 21 families.

Deltas C, Gale D, Cook T, Voskarides K, Athanasiou Y, Pierides A.

Adv Exp Med Biol. 2013;735:189-96. Review.

PMID:
23402027
34.

On 'Incidence of renal failure and nephroprotection by RAAS inhibition in heterozygous carriers of X-chromosomal and autosomal recessive Alport mutations'.

Voskarides K, Pierides A, Deltas C.

Kidney Int. 2013 Feb;83(2):331. doi: 10.1038/ki.2012.376. No abstract available.

35.

Residual renal function in hemodialysis patients: the role of Angiotensin-converting enzyme inhibitor in its preservation.

Xydakis D, Papadogiannakis A, Sfakianaki M, Kostakis K, Stylianou K, Petrakis I, Ergini A, Voskarides K, Dafnis E.

ISRN Nephrol. 2012 Dec 24;2013:184527. doi: 10.5402/2013/184527. eCollection 2013.

36.

A miR-1207-5p binding site polymorphism abolishes regulation of HBEGF and is associated with disease severity in CFHR5 nephropathy.

Papagregoriou G, Erguler K, Dweep H, Voskarides K, Koupepidou P, Athanasiou Y, Pierides A, Gretz N, Felekkis KN, Deltas C.

PLoS One. 2012;7(2):e31021. doi: 10.1371/journal.pone.0031021. Epub 2012 Feb 2.

37.

Evidence that NPHS2-R229Q predisposes to proteinuria and renal failure in familial hematuria.

Voskarides K, Arsali M, Athanasiou Y, Elia A, Pierides A, Deltas C.

Pediatr Nephrol. 2012 Apr;27(4):675-9. doi: 10.1007/s00467-011-2084-6. Epub 2012 Jan 8.

PMID:
22228437
38.

The role of molecular genetics in diagnosing familial hematuria(s).

Deltas C, Pierides A, Voskarides K.

Pediatr Nephrol. 2012 Aug;27(8):1221-31. doi: 10.1007/s00467-011-1935-5. Epub 2011 Jun 19. Review.

39.

Familial C3 glomerulopathy associated with CFHR5 mutations: clinical characteristics of 91 patients in 16 pedigrees.

Athanasiou Y, Voskarides K, Gale DP, Damianou L, Patsias C, Zavros M, Maxwell PH, Cook HT, Demosthenous P, Hadjisavvas A, Kyriacou K, Zouvani I, Pierides A, Deltas C.

Clin J Am Soc Nephrol. 2011 Jun;6(6):1436-46. doi: 10.2215/CJN.09541010. Epub 2011 May 12.

40.

Increased number of microRNA target sites in genes encoded in CNV regions. Evidence for an evolutionary genomic interaction.

Felekkis K, Voskarides K, Dweep H, Sticht C, Gretz N, Deltas C.

Mol Biol Evol. 2011 Sep;28(9):2421-4. doi: 10.1093/molbev/msr078. Epub 2011 Mar 25.

PMID:
21441354
41.

X-linked Alport syndrome in Hellenic families: phenotypic heterogeneity and mutations near interruptions of the collagen domain in COL4A5.

Demosthenous P, Voskarides K, Stylianou K, Hadjigavriel M, Arsali M, Patsias C, Georgaki E, Zirogiannis P, Stavrou C, Daphnis E, Pierides A, Deltas C; Hellenic Nephrogenetics Research Consortium.

Clin Genet. 2012 Mar;81(3):240-8. doi: 10.1111/j.1399-0004.2011.01647.x. Epub 2011 Mar 13.

PMID:
21332469
42.

Founder mutations in the ATP6V1B1 gene explain most Cypriot cases of distal renal tubular acidosis: first prenatal diagnosis.

Elia A, Voskarides K, Demosthenous P, Michalopoulou A, Malliarou MA, Georgaki E, Athanasiou Y, Patsias C, Pierides A, Deltas C.

Nephron Clin Pract. 2011;117(3):c206-12. doi: 10.1159/000320192. Epub 2010 Aug 30.

PMID:
20805693
43.

Identification of a mutation in complement factor H-related protein 5 in patients of Cypriot origin with glomerulonephritis.

Gale DP, de Jorge EG, Cook HT, Martinez-Barricarte R, Hadjisavvas A, McLean AG, Pusey CD, Pierides A, Kyriacou K, Athanasiou Y, Voskarides K, Deltas C, Palmer A, Frémeaux-Bacchi V, de Cordoba SR, Maxwell PH, Pickering MC.

Lancet. 2010 Sep 4;376(9743):794-801. doi: 10.1016/S0140-6736(10)60670-8. Epub 2010 Aug 25.

44.

Screening for mutations in kidney-related genes using SURVEYOR nuclease for cleavage at heteroduplex mismatches.

Voskarides K, Deltas C.

J Mol Diagn. 2009 Jul;11(4):311-8. doi: 10.2353/jmoldx.2009.080144. Epub 2009 Jun 12.

45.

Clinico-pathological correlations in 127 patients in 11 large pedigrees, segregating one of three heterozygous mutations in the COL4A3/ COL4A4 genes associated with familial haematuria and significant late progression to proteinuria and chronic kidney disease from focal segmental glomerulosclerosis.

Pierides A, Voskarides K, Athanasiou Y, Ioannou K, Damianou L, Arsali M, Zavros M, Pierides M, Vargemezis V, Patsias C, Zouvani I, Elia A, Kyriacou K, Deltas C.

Nephrol Dial Transplant. 2009 Sep;24(9):2721-9. doi: 10.1093/ndt/gfp158. Epub 2009 Apr 8.

PMID:
19357112
46.

COL4A3/COL4A4 mutations link familial hematuria and focal segmental glomerulosclerosis. glomerular epithelium destruction via basement membrane thinning?

Voskarides K, Pierides A, Deltas C.

Connect Tissue Res. 2008;49(3):283-8. doi: 10.1080/03008200802148280.

PMID:
18661361
47.

COL4A3 founder mutations in Greek-Cypriot families with thin basement membrane nephropathy and focal segmental glomerulosclerosis dating from around 18th century.

Voskarides K, Patsias C, Pierides A, Deltas C.

Genet Test. 2008 Jun;12(2):273-8. doi: 10.1089/gte.2007.0110.

PMID:
18439107
48.

NPHS2 screening with SURVEYOR in Hellenic children with steroid-resistant nephrotic syndrome.

Voskarides K, Makariou C, Papagregoriou G, Stergiou N, Printza N, Alexopoulos E, Elia A, Papachristou F, Pierides A, Georgaki E, Deltas C.

Pediatr Nephrol. 2008 Aug;23(8):1373-5. doi: 10.1007/s00467-008-0804-3. Epub 2008 Apr 5. No abstract available.

PMID:
18392643
49.

COL4A3/COL4A4 mutations producing focal segmental glomerulosclerosis and renal failure in thin basement membrane nephropathy.

Voskarides K, Damianou L, Neocleous V, Zouvani I, Christodoulidou S, Hadjiconstantinou V, Ioannou K, Athanasiou Y, Patsias C, Alexopoulos E, Pierides A, Kyriacou K, Deltas C.

J Am Soc Nephrol. 2007 Nov;18(11):3004-16. Epub 2007 Oct 17.

50.

Ischemic but not mechanical preconditioning attenuates ischemia/reperfusion induced myocardial apoptosis in anaesthetized rabbits: the role of Bcl-2 family proteins and ERK1/2.

Lazou A, Iliodromitis EK, Cieslak D, Voskarides K, Mousikos S, Bofilis E, Kremastinos DT.

Apoptosis. 2006 Dec;11(12):2195-204.

PMID:
17051325

Supplemental Content

Loading ...
Support Center